Search For "oral antiviral"
Hetero's 'Nirmacom' is world's first generic version of COVID-19 oral drug
Updated : 3 years, 5 months ago IST
Hyderabad (Telangana) [India], December 27 (ANI/PRNewswire): Hetero, India's leading pharmaceutical company with the widest global reach, today announced the receipt of World Health Organization Prequalification of Medicines Program (WHO PQ) approval for its generic version of COVID-19 oral
Read More
Australia promotes oral antiviral treatments amid COVID-19 surge in winter
Updated : 3 years, 10 months ago IST
Canberra [Australia], July 22 (ANI/Xinhua): The Australian government has launched a campaign to encourage the uptake of antiviral treatments for coronavirus amid surging COVID-19 cases in winter.
Read More
Zambia to start administering oral antiviral COVID-19 pills
Updated : 3 years, 10 months ago IST
Lusaka [Zambia], July 8 (ANI/Xinhua): Zambia will soon start administering Paxlovid, an oral antiviral pill, to people at risk of developing severe COVID-19 disease, its health ministry said on Friday.
Read More
Oral antiviral drug targets key part of respiratory syncytial virus: Study
Updated : 3 years, 11 months ago IST
Washington [US], June 26 (ANI): An oral antiviral drug that targets a key part of the respiratory syncytial virus (RSV) polymerase and inhibits the synthesis of viral genetic material has been identified, a finding that could provide an effective treatment against RSV disease.
Read More
Don't use Molnupiravir for treating COVID-19 in younger population, warns
Updated : 4 years, 4 months ago IST
New Delhi [India], January 11 (ANI): Molnupiravir, an oral antiviral drug used in the treatment of COVID-19 should not be administered to the younger population as it adversely affects their reproductive system, said Dr NK Arora, Chairman of COVID-19 Working Group of National Technical Advis
Read More
DCGI grants Cipla emergency use authorisation for COVID-19 drug Molnupirav
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], December 28 (ANI): Drug Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Cipla for the launch of Molnupiravir in the country for COVID-19 treatment.
Read More
Sri Lanka approves first oral antiviral pill to treat COVID-19
Updated : 4 years, 6 months ago IST
Colombo [Sri Lanka], November 16 (ANI/Xinhua): Sri Lankan government has endorsed the use of Molnupiravir, the first oral antiviral pill to treat patients infected with SARS-CoV-2, the country's health minister said Tuesday.
Read More
Pfizer says its COVID-19 oral antiviral candidate reduces risk of hospital
Updated : 4 years, 6 months ago IST
New York [US], November 5 (ANI): American pharmaceutical company Pfizer announced on Friday that its investigational COVID-19 oral antiviral candidate, Paxlovid, showed an 89 per cent reduction in hospitalisation or lethal cases in high-risk patients.
Read More
Pfizer begins early stage trial for oral COVID-19 drug
Updated : 5 years, 2 months ago IST
New York [US], March 24 (ANI): Pfizer has said that it has begun early-stage clinical trials of an investigational, oral antiviral drug for Covid-19.
Read More
Recently published data on Favipiravir as treatment for mild to moderate C
Updated : 5 years, 6 months ago IST
Mumbai (Maharashtra) [India], November 23 (ANI/PRNewswire): The oral antiviral medication Favipiravir, that prevents the replication phase of the virus life-cycle, leads to significant improvement in clinical cure in patients with mild to moderate COVID-19.
Read More
Glenmark introduces higher strength (400 mg) of FabiFlu® to reduce th
Updated : 5 years, 9 months ago IST
Mumbai (Maharashtra) [India] Aug 6 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, today announced that it will introduce a 400 mg version of oral antiviral FabiFlu®, for the treatment of mild to moderate COVID-19 in India.
Read More
Glenmark commences 1000 patients Post Marketing Surveillance study with CO
Updated : 5 years, 10 months ago IST
Mumbai (Maharashtra) [India], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu® to closely monitor the efficacy and safety of the drug in
Read More